- Home
- TNGX vs TRAK Comparison
TNGX vs TRAK Comparison
Compare TNGX & TRAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- TRAK
- Stock Information
- Founded
- TNGX 2014
- TRAK 1990
- Country
- TNGX United States
- TRAK United States
- Employees
- TNGX N/A
- TRAK N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- TRAK EDP Services
- Sector
- TNGX Health Care
- TRAK Technology
- Exchange
- TNGX Nasdaq
- TRAK Nasdaq
- Market Cap
- TNGX 317.4M
- TRAK 366.3M
- IPO Year
- TNGX N/A
- TRAK 1998
- Fundamental
- Price
- TNGX $1.29
- TRAK $20.19
- Analyst Decision
- TNGX Strong Buy
- TRAK Strong Buy
- Analyst Count
- TNGX 7
- TRAK 1
- Target Price
- TNGX $12.33
- TRAK $24.00
- AVG Volume (30 Days)
- TNGX 756.3K
- TRAK 59.4K
- Earning Date
- TNGX 05-07-2025
- TRAK 05-14-2025
- Dividend Yield
- TNGX N/A
- TRAK 0.36%
- EPS Growth
- TNGX N/A
- TRAK 14.28
- EPS
- TNGX N/A
- TRAK 0.32
- Revenue
- TNGX $42,069,000.00
- TRAK $21,199,507.00
- Revenue This Year
- TNGX N/A
- TRAK $15.61
- Revenue Next Year
- TNGX N/A
- TRAK $15.00
- P/E Ratio
- TNGX N/A
- TRAK $63.13
- Revenue Growth
- TNGX 15.17
- TRAK 6.99
- 52 Week Low
- TNGX $1.11
- TRAK $14.23
- 52 Week High
- TNGX $12.02
- TRAK $25.01
- Technical
- Relative Strength Index (RSI)
- TNGX 37.63
- TRAK 54.14
- Support Level
- TNGX $1.25
- TRAK $19.79
- Resistance Level
- TNGX $1.44
- TRAK $20.37
- Average True Range (ATR)
- TNGX 0.15
- TRAK 1.05
- MACD
- TNGX 0.03
- TRAK 0.14
- Stochastic Oscillator
- TNGX 45.00
- TRAK 89.94
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.
About TRAK ReposiTrak Inc.
ReposiTrak Inc is a software as a service provider with extensive capabilities that gives their customers an easy, cost-efficient way to expand their services to their benefit. The company and its subsidiaries develop, market, and support proprietary software products. These products assist the management of business operations, which helps clients to make more informed decisions. The company also provides a cloud-based solution to remain in compliance with business records and regulatory requirements. The firm's services comprise implementation, business optimization, outsourcing, technical services, education, and application hosting.